{"id":"NCT01226459","sponsor":"Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.","briefTitle":"Clinical Trial in Females for Female Pattern Hair Loss","officialTitle":"A Phase 3 Multi-Center Parallel Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam vs. Vehicle in Females for the Treatment of Female Pattern Hair Loss (Androgenetic Alopecia)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-09","primaryCompletion":"2011-08","completion":"2011-08","firstPosted":"2010-10-22","resultsPosted":"2014-06-03","lastUpdate":"2014-06-10"},"enrollment":404,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Androgenetic Alopecia"],"interventions":[{"type":"DRUG","name":"5% Minoxidil Topical Foam","otherNames":["Not yet marketed"]},{"type":"DRUG","name":"Vehicle Topical Foam","otherNames":["Vehicle Control (Placebo)"]}],"arms":[{"label":"Minoxidil Foam","type":"EXPERIMENTAL"},{"label":"Vehicle Foam","type":"PLACEBO_COMPARATOR"}],"summary":"This is a six month clinical trial to evaluate the effectiveness and safety in women with Female Pattern Hair Loss (FPHL), comparing a 5% minoxidil topical foam (MTF) formulation applied once a day versus a topical foam vehicle (placebo) formulation applied once a day.","primaryOutcome":{"measure":"Target Area Hair Count","timeFrame":"Baseline to Week 24","effectByArm":[{"arm":"Vehicle Foam","deltaMin":152.7,"sd":59.7},{"arm":"Minoxidil Foam","deltaMin":158.6,"sd":61.6}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":10},"locations":{"siteCount":17,"countries":["United States","France","Germany","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":201},"commonTop":["Weight Increased","Nasopharyngitis","Headache","Upper Respiratory Tract Infection","Sinusitis"]}}